Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
CNSSU On Other Exchanges
Symbol
Exchange
OTC US
OTC US
All times are local (Market data is delayed by at least 15 minutes).

cns response inc-unit (CNSSU) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CNS RESPONSE INC-UNIT (CNSSU)

cns response inc-unit (CNSSU) Related Bloomberg News

View More Bloomberg News

cns response inc-unit (CNSSU) Related Businessweek News

No Related Businessweek News Found

cns response inc-unit (CNSSU) Details

CNS Response, Inc. operates as a cloud-based predictive analytics company. It provides clinical decision support to mental healthcare providers for the treatment of behavioral disorders, including depression, anxiety, bipolar disorder, and post-traumatic stress disorder. The company uses its proprietary neurometric platform, PEER Online, to generate Psychiatric EEG Evaluation Registry (PEER) reports to predict the likelihood of response by an individual to certain medications for the treatment of behavioral disorders. It offers PEER reports to medical professionals, which summarize the historical treatment efficacy of specific medications for those patients with similar neurometric brain patterns. CNS Response, Inc. is headquartered in Aliso Viejo, California.

cns response inc-unit (CNSSU) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: $270.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $208.0K
Chief Medical Officer
Total Annual Compensation: $89.3K
Compensation as of Fiscal Year 2014.

cns response inc-unit (CNSSU) Key Developments

CNS Response, Inc. Announces Board Changes

Effective August 20, 2015, the Board of Directors of CNS Response, Inc. appointed Robin L. Smith, M.D., to the company's board and to serve as its Chairman. Dr. Smith was also appointed to the Governance and Nominations Committee, and will serve as its Chair. Dr. Robin L. Smith, is currently the Chairman of the Board of Directors of Caladrius Biosciences. Dr. Smith has an extensive and diversified background in health care, sales and marketing, business development and management. Her previous experience includes serving as President and Chief Executive Officer of IP2M. She also previously held the position of Executive Vice President and Chief Medical Officer for HealthHelp, Inc. Dr. Smith also currently serves on the Board of Directors of Signal Genetics. She served on the Board of Trustees of the NYU Langone Medical Center and is past Chairman of the Board of Directors for the New York University Hospital for Joint Diseases. Currently, Dr. Smith is the President and Chairman of the Board of Directors of The Stem for Life Foundation, a non-profit entity that seeks to create a movement to accelerate development of cell therapies which are believed to hold the promise to cure many of the world's most debilitating illnesses as opposed to merely treating their symptoms. She also serves on the Board of Directors of the Science and Faith STOQ Foundation in Rome, as well as on the Capital Formation Committee of the Alliance for Regenerative Medicine.

CNS Response, Inc. Appoints Geoffrey E. Harris and Michal Votruba to its Board

Effective July 30, 2015, the Board of Directors of CNS Response, Inc. appointed Geoffrey E. Harris and Michal Votruba to the Company’s Board. Mr. Harris is the Managing Partner of C7 Advisors. Mr. Harris is also currently on the board of directors of Cancer Genetics, Inc. Mr. Votruba is the Director for Life Sciences for the RSJ/Gradus Fund.

CNS Response, Inc. Announces the Resignation of Walter L. Schindler from the Board

On June 11, 2015, Walter L. Schindler, a member of the board of directors of CNS Response, Inc. and a member of the Compensation Committee of the board, notified the company of his decision to resign from the board, effective immediately. Mr. Schindler has served on the Board since November 28, 2012.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CNSSU:US $0.00 USD 0.00

CNSSU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brain Resource Ltd A$0.17 AUD 0.00
General Electric Co $25.01 USD +1.00
International Business Machines Corp $148.54 USD +1.84
Microsoft Corp $43.90 USD +1.19
View Industry Companies
 

Industry Analysis

CNSSU

Industry Average

Valuation CNSSU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 51.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 28.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CNS RESPONSE INC-UNIT, please visit www.CNSResponse.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.